Mednet Logo
SpecialtiesNeurology
Neurology

Neurology

Expert perspectives on neurological conditions, stroke management, movement disorders, and neuromuscular disease.

Recent Discussions

How do you evaluate and manage brain fog in patients with underlying rheumatic disease?

3
7 Answers

Mednet Member
Mednet Member
Rheumatology · The University of Michigan

For Brain fog – Most important this is I stress to patients – there are likely MULTIPLE different things contributing to brain fog, so there are MULTIPLE different things we are going to have to work on to improve it. Active inflammation might be contributing, but there is likely several other facto...

How do you approach questions regarding clearance for elective surgery in patients with epilepsy?

1
3 Answers

Mednet Member
Mednet Member
Neurology · University of Rochester Medical Center

I write a letter that gives a sense of how well-controlled the epilepsy is, emphasizes that ASMs should be taken on the morning of surgery as usual, and if hospital admission is needed, that they should be given on schedule during the admission as well. I then give some general tips on seizure first...

When do you obtain nerve biopsy to evaluate for vasculitic neuropathy in patients with distal symmetric polyneuropathies?

1
1 Answers

Mednet Member
Mednet Member
Neurology · University of Minnesota

Excellent question. Vasculitic neuropathies can occur as part of systemic or isolated peripheral nerve vasculitis (PNSV). While the majority of PNSV presents as mononeuropathy multiplex (>50%), it is well known that the rest of the patients present either with confluent mononeuropathies (which began...

What treatments, after appropriate dose reductions/delays, do you offer for patients with oxaliplatin-induced cold allodynia/dysesthesia?

1
4 Answers

Mednet Member
Mednet Member
Medical Oncology · Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center

The primary treatments that I use for cold-induced oxaliplatin neurotoxicity are reducing the oxaliplatin dose and limiting the duration of oxaliplatin treatment (usually not more than 16 weeks of oxaliplatin-containing therapy in the initial line of treatment). Medications that are effective for pa...

How do you use Boswellia for radiation necrosis?

8
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Harbin Clinic

I reached out to my colleague, naturopath Lise Alschuler, Associate Director of the University of Arizona Fellowship Program in Integrative Medicine program, for her thoughts on this question. Here is her answer:This study by Upadhyay et al. is a well-designed study which builds upon earlier studies...

How do you treat agitation in progressive supranuclear palsy?

1
1 Answers

Mednet Member
Mednet Member
Psychiatry · University of Washington

Benzodiazepines are generally avoided due to adverse effects on cognition, the increased risk of falls, and disinhibition.Pharmacologic treatment for agitation is generally reserved for patients with severe agitation, when a patient is a threat to themselves and others, when agitation is the cause o...

What is your approach to tapering anesthetic drips for refractory status epilepticus after achieving burst suppression?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Stanford Health Care Stroke Center

Ensure adequate oral/IV ASMs are on board, targeting the receptors appropriately based on the type of status- generalized, focal (e.g., GABA, Na channel, glutamate, etc.). These would include the first, second, and third line as per status protocols. Check levels to ensure adequacy. At least 24 hou...

What factors do you take into account when deciding the length of adjuvant temozolamide in GBM?

3
1 Answers

Mednet Member
Mednet Member
Neurology · MD Anderson Cancer Center

The field is evolving from 12 cycles to 6 for IDH-wildtype GBM in recent years, on the basis of some retrospective studies and notably the prospective Spanish study GEINO 14-01 - there does not seem to be much OS benefit, and there are also toxicity concerns (myelosuppression, hypermutation). Extens...

How often do you perform surveillance brain MRIs in patients with MS on highly effective DMTs?

1
1 Answers

Mednet Member
Mednet Member
Neurology · University of Kentucky

The so-called guidelines to do MRIs on an annual basis pre-dated the introduction of anti-CD20 drugs. After these drugs were introduced in 2017, the need for MRIs has fallen off a cliff (as it ought to). With 95% or better suppression of new disease activity (inflammatory component and not the iron...

How do you counsel women on anti-CD20 therapy for MS who are planning for pregnancy?

1
1 Answers

Mednet Member
Mednet Member
Neurology · Cleveland Clinic

I counsel patients that anti-CD20 therapies are relatively safe in patients with MS who are considering pregnancy. Monoclonal antibodies are not transported across the placenta until the 2nd trimester, and with a half-life of 20-30 days (depending on which anti-CD 20 is used), the amount that crosse...